MORRISVILLE, N.C., Oct. 31, 2013 — SafeStitch Medical, Inc. (OTCBB: SFES), which recently merged with TransEnterix, Inc., announced today that it plans to release third quarter 2013 financial and operating results after market close on Tuesday, November 12, 2013. Todd Pope, Chief Executive Officer and Joe Slattery, Executive Vice President and Chief Financial Officer will host a conference call to discuss these results starting at 4:30 p.m. Eastern Time the same day.

To listen to the conference call on your telephone, please dial 866-318-8617 for domestic callers or 617-399-5136 for international callers approximately ten minutes prior to the start time. The call will be concurrently webcast. To access the live audio broadcast or archived recording, use the following link www.transenterix.com/investors.php.

About SafeStitch Medical (TransEnterix)
SafeStitch Medical (TransEnterix) is a development stage medical device company that is pioneering the use of flexible instruments and robotics to improve how minimally invasive surgery is performed. The company is focused on the development and commercialization of SurgiBot, a novel patient side minimally invasive surgical robotic system. For more information, visit the company’s websites at www.transenterix.com and www.safestitch.com.

Contact:
Westwicke Partners
Mark Klausner, 443-213-0501
transenterix@westwicke.com